GANX
#4071
Gain Therapeutics, Inc. - Common Stock
1.7 7 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.32%
Monthly Change
+4.12%
6 month change
-31.92%
Year Change
-7.81%
Previous Close
1.8 5
Open
1.7 7
Low
1.7 7
High
1.7 7
Volume
8
Financials
- Market Capitalization 77.25 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.gaintherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00W7D7CJ9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.28
Price to sales ratio
-127.34
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4064 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.14 USD | -4.20% | +0.88% | -6.56% | -12.31% | 78.40 M USD | ||
| 4068 |  CING Cingulate Inc. - Common Stock | 5.33 USD | -2.02% | -3.27% | +17.66% | -13.47% | 77.51 M USD | ||
| 4087 |  LONA LeonaBio, Inc. - Common Stock | 8.00 USD | +1.39% | +5.68% | +11.11% | +18.69% | 75.37 M USD | ||
| 4088 |  RNXT RenovoRx, Inc. - Common Stock | 1.67 USD | +12.84% | +25.56% | +83.52% | +73.96% | 75.37 M USD |
Frequently asked questions about Gain Therapeutics, Inc. Common Stock
What is the Gain Therapeutics, Inc. Common Stock stock price today?
The current price of Gain Therapeutics, Inc. Common Stock (GANX) is 1.77. Over the past 24 hours, the stock has changed by -4.32%. Follow the GANX chart for real-time price dynamics.
What is the stock ticker of Gain Therapeutics, Inc. Common Stock?
Gain Therapeutics, Inc. Common Stock trades under the ticker GANX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gain Therapeutics, Inc. Common Stock stock going up?
GANX has changed by -11.94% over the last week, +4.12% over the last month, and -7.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Gain Therapeutics, Inc. Common Stock?
Gain Therapeutics, Inc. Common Stock currently has a market capitalization of 77.25 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Gain Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Gain Therapeutics, Inc. Common Stock reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Gain Therapeutics, Inc. Common Stock revenue for the last quarter?
Gain Therapeutics, Inc. Common Stock reported quarterly revenue of 49.09 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Gain Therapeutics, Inc. Common Stock net income for the last quarter?
Gain Therapeutics, Inc. Common Stock reported net income of -4.68 M for the last quarter. The previous quarter showed -5.61 M, which means net income changed by +16.64%.
How many employees does Gain Therapeutics, Inc. Common Stock have?
As of the latest available data, Gain Therapeutics, Inc. Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gain Therapeutics, Inc. Common Stock EBITDA?
Gain Therapeutics, Inc. Common Stock EBITDA is -4.61 M, and its EBITDA margin is -9 381.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gain Therapeutics, Inc. Common Stock stock?
You can buy Gain Therapeutics, Inc. Common Stock (GANX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gain Therapeutics, Inc. Common Stock stock?
Investing in Gain Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GANX chart and related analysis on metatrader.com as part of your research.